3 Human Clinical Trials on NEM® (Natural Eggshell Membrane) featured in Membrell’s JOINThealth products

Membrell’s JOINThealth products feature NEM® or Natural Eggshell Membrane.  There have been 3 human clinical trials conducted on NEM® proving its efficacy on improving joint comfort and flexibility in as little as 7 to 10 days, in a very convenient dosage of one small, 500mg pill per day.  There are two open label, human clinical trials and the randomized, double blind, placebo controlled human clinical trial.

Open Label Human Clinical Trials on NEM®

The results of the 2 open label studies showed that supplementation with NEM® produced an average 25% reduction in pain (Study 2) & an average 28% increase in flexibility (Study 1) in just 7 days. By the end of the 30-day trial, patients in Study 1 had an average reduction in pain of more than 72% (See graph, below) and nearly half of these patients reported that they were completely pain-free by the end of the study. Flexibility had improved by an average 44% (Study 1) (See graph, right) with more than half of the patients experiencing greater than 50% improvement in flexibility by the end of the study. NEM® not only improved flexibility, it also reduced the pain patients experienced while flexing the affected joint (range of motion – ROM) by 76% (See graph inset, right). No side effects were reported by study participants.

x

Double Blind Human Clinical Trial

(OPTION Study) In a randomized, double blind, placebo controlled human clinical study being prepared for publication, orally administered NEM® produced an average 15% reduction in pain & an average 13% reduction in stiffness in just 10 days. By the end of the 60-day trial, a full third of the patients had experienced a greater than 50% reduction in pain & more than half of the patients had experienced a greater than 50% reduction in stiffness. Again, noside effects were reported by study participants.